Alpha Teknova, Inc. (TKNO) Revenue History
Alpha Teknova, Inc. (TKNO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $36.89M |
| 2022-12-31 | $41.42M |
| 2023-12-31 | $36.68M |
| 2024-12-31 | $37.74M |
| 2025-12-31 | $40.52M |
How TKNO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| VSTM | Verastem Inc. | $30.91M |
These are five companies in the same sector as TKNO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Alpha Teknova, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TKNO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TKNO | $7.36 | +5.14% | 0.22M |
| 3 | ||||
| 4 | ||||
| 5 |